Which federal agency does American Academy of Pediatrics (AAP) comment on most?

American Academy of Pediatrics (AAP) is most active at the Food and Drug Administration.

← OpenPolis Sign in

American Academy of Pediatrics (AAP)

Unclaimed

Industry

Nonprofit management

Staff

1,200

345 Park Blvd, Itasca, IL 60143

Phone

+1 847-434-4000

Website

aap.org

Engagement overview

American Academy of Pediatrics (AAP) has filed 483 public comments across 363 dockets at 25 federal agencies, most actively at the Food and Drug Administration.

American Academy of Pediatrics (AAP)

Engagement overview

Is this your organization?

Agency footprint

Dockets · FDA (125)

Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments

AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability

Modified Risk Tobacco Product Application: Applications for ZYN products Submitted by Swedish Match U.S.A. Inc.

Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use

Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs

Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

Food Safety and Inspection Service Ultra-Processed Foods; Request for Information

Infant Formula Nutrient Requirements; Request for Information

Reauthorization of the Medical Device User Fee Amendments; Public Meeting; Request for Comments

Food Labeling: Front-of-Package Nutrition Information

Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments

Over-the-Counter Monograph Condition B001: Single-Unit or Unit-Dose Containers for Over-the-Counter Monograph Drugs in Orally Disintegrating Tablet and Film Dosage Forms

Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments

Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability

Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

Listening Session: Optimizing FDA’s Use of and Processes for Advisory Committees; Public Meeting; Request for Comments

Banned Devices; Proposal to Ban Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior Center: Center for Devices and Radiological Health

Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act

Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Draft Guidance for Industry; Availability

Action Levels for Lead in Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability

Use of the Term “Healthy” in the Labeling of Human Food Products

Ethical Considerations for Clinical Investigations of Medical Products Involving Children; Draft Guidance for Industry, Sponsors, and IRBs; Availability

Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments

Tobacco Product Standard for Menthol in Cigarettes

Tobacco Product Standard for Characterizing Flavors in Cigars

Modified Risk Tobacco Product Application: Application for the IQOS 3 System Holder and Charger Submitted by Phillip Morris Products S.A

Closer to Zero Action Plan: Impacts of Toxic Element Exposure and Nutrition at Different Crucial Developmental Stages”; Public Meeting; Request for Comments

Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies; Draft Guidance for Industry; Availability

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments

Vaccines and Related Biological Products Advisory Committee

Use of Codeine-Containing Analgesics in Children Under 12 Years of Age Subsequent to CYP2D6 Genetic Testing; Establishment of a Public Docket; Request for Comments

Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List

Fixed-Quantity Unit-of-Use Blister Packaging for Certain Immediate-Release Opioid Analgesics for Treatment of Acute Pain; Establishment of a Public Docket; Request for Comments

Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments

Sunscreen Drug Products -OPEN

Youth Tobacco Cessation: Science and Treatment Strategies; Public Scientific Workshop; Request for Comments

Cancer Clinical Trial Eligibility Criteria: Minimum Age for Pediatric Patients; Draft Guidance for Industry; Availability

Use of Dairy Terms in the Labeling of Plant-Based Products

Eliminating Youth Electronic Cigarette and Other Tobacco Product Use: The Role for Drug Therapies; Public Hearing; Request for Comments

Sesame as an Allergen in Foods

Regulation of Flavors in Tobacco Products

Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials; Draft Guidance for Industry; Availability

Pediatric HIV Infection: Drug Development for Treatment; Draft Guidance for Industry; Availability

Tobacco Product Standard for Nicotine Level of Combusted Cigarettes

Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials

Drug Products Labeled as Homeopathic

FDA’s Approach to Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments

Packaging, Storage, and Disposal Options To Enhance Opioid Safety-Exploring the Path Forward; Public Workshop; Request for Comments,”

Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations of Common Diseases

Review of Existing General Regulatory and Information Collection Requirements of the Food and Drug Administration

Modified Risk Tobacco Product Applications: Applications for IQOS System with Marlboro Heatsticks, IQOS System with Marlboro Smooth Menthol Heatsticks, and IQOS System with Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A.

Food Labeling: Revision of the Nutrition and Supplement Facts Labels

Experimental Study on Warning Statements for Cigarette Graphic Health Warnings

Child-Resistant Packaging Statements in Drug Product Labeling

FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids

General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products

Tobacco Product Standard for N-nitrosonornicotine Level in Finished Smokeless Tobacco Products

Pediatric Studies of Drugs Provision of FDAMA - Section 505A-CLOSED

Substantiation for Structure/Function Claims Made in Infant Formula Labels and Labeling

Banned Devices; Proposal to Ban Electrical Stimulation Devices Used to Treat Self-Injurious or Aggressive Behavior

Over-the-Counter Sunscreens: Safety and Effectiveness Data

Inorganic Arsenic in Rice Cereals for Infants: Action Level; Draft Guidance for Industry; Supporting Document for Action Level for Inorganic Arsenic in Rice Cereals for Infants; Arsenic in Rice and Rice Products Risk Assessment

Microbiology Devices; Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly with Clinical Specimens

Patient and Medical Professional Perspectives on the Return of Genetic Test Results

Renaming of Pediatric Hospital Bed Classification and Designation of Special Controls for Pediatric Medical Crib; Classification of Medical Bassinet

To Amend the Standard of Identity for Milk, 21 C.F.R. 131.110, to Includes Optional Characterizing Flavoring Ingredients With any Safe and Suitable Sweetener

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AH-7921; Gamma-Butyrolactone (GBL); 1,4-Butanediol; 9 Additional Substances; Request for Comments

Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices

Humanitarian Device Exemption (HDE): Questions and Answers

Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED

Issue a Federal Regulation to Augment FDA Citizen's Petition For Public Hearings to Establish Standards on Cellphone Radiation Adverse Health Effects That Might be Caused by Specific Absorption Rates (SAR) and Radio Frequency Radiation (RFR)/Electromagnetic Frequency (EMF) Closed

Reference Daily Intake&Daily Reference Values/Food Labeling - CLOSED

Guidance for Industry on General Clinical Pharmacology Consideration for Pediatric Studies for Drugs and Biological Products